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Abstract 36 
Objectives: From 2012-2015, a sudden huge increase of vancomycin-resistant (vanA) Enterococcus 37 
faecium (VREfm) was observed in the Capital Region of Denmark. Clonal relatedness of VREfm and 38 
vancomycin-susceptible E. faecium (VSEfm) was investigated, transmission events between hospitals 39 
were identified and the pan-genome and plasmids from the largest VREfm clonal group were 40 
characterized. 41 
Methods: WGS of 1058 E. faecium isolates was carried out on the Illumina platform to perform SNP-42 
analysis and to identify the pan-genome. One isolate was also sequenced on the PacBio platform to close 43 
the genome. Epidemiological data were collected from laboratory information systems. 44 
Results: Phylogeny of 892 VREfm and 166 VSEfm revealed a polyclonal structure with a single clonal 45 
group (ST80) accounting for 40% of the VREfm isolates. VREfm and VSEfm co-occurred within many 46 
clonal groups; however, no VSEfm were related to the dominant VREfm group. A similar vanA plasmid 47 
was identified in ≥99% of isolates belonging to the dominant group and 69% of the remaining VREfm. 48 
Ten plasmids were identified in the completed genome and approximately 29% of this genome consisted 49 
of dispensable accessory genes. The size of the pan-genome among isolates in the dominant group was 50 
5,905 genes. 51 
Conclusions: Most likely, VREfm emerged due to import of a successful VREfm clone which has 52 
rapidly transmitted to the majority of hospitals in the region whilst simultaneously disseminating a vanA 53 
plasmid to pre-existing VSEfm. Acquisition of a heterogeneous accessory genome may account for the 54 
success of this clone by facilitating adaption to new environmental challenges. 55 
 56 
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Introduction 71 
Enterococcus faecium, a commensal in the gut, has emerged as an increasingly important nosocomial 72 
pathogen causing bacteraemia, intra-abdominal, urinary tract and intravenous -catheter related infections.1 73 
Acquired resistance to ampicillin, gentamicin (high-level) and vancomycin has increased worldwide 74 
among hospital-associated E. faecium narrowing treatment options of enterococcal infections.2-5 Patients, 75 
asymptomatically colonized with vancomycin-resistant E. faecium (VREfm) in the GI-tract act as both a 76 
reservoir and a source for dissemination of VREfm into the hospital environment.6 This makes infection 77 
control of this problem pathogen highly challenging. Previous studies have identified two to ten 78 
asymptomatic VREfm carriers for each patient with a clinical VREfm isolate.6  79 
Vancomycin is first line treatment of infections caused by E. faecium. Therefore, it was of 80 
great concern when the incidence of vanA VREfm started to increase in the Capital Region of Denmark in 81 
2012.7 More than 1,500 VREfm patients were identified from 2012 to 2015, contrasting with only 9 82 
patients infected or colonised in 2011.8, 9  83 
We recently reported on WGS of 495 VREfm isolates identified from the Capital Region 84 
of Denmark from 2012-2014 and observed a polyclonal outbreak characterized by the spread of a highly 85 
successful plasmid (pHvH-V24, KX574671.1), which conferred resistance to vancomycin through the 86 
presence of a vanA gene complex.10 This vanA plasmid had been acquired by >90% of the VREfm clonal 87 
groups. Therefore, we developed the hypothesis that a VREfm clone, containing a vanA plasmid, has been 88 
introduced to the Capital Region of Denmark and the plasmid was disseminated via horizontal gene 89 
transfer to pre-existing hospital-adapted vancomycin-susceptible E. faecium (VSEfm) clonal groups. 90 
Hospital-associated  E. faecium are known to rapidly acquire mobile genetic elements 91 
(MGE) and, as a result, they harbour plasmids and insertion elements that confer resistance, virulence and 92 
other clinically relevant phenotypes.11, 12 More detailed molecular data on MGEs, the accessory genome 93 
and comparison to VSEfm are therefore necessary to understand how VREfm and resistance determinants 94 
disseminate in the hospital environment. 95 
Here, we applied short- and long-read sequencing along with epidemiological data to 96 
understand the sudden increase of VREfm in the low prevalence Capital Region of Denmark from 2012-97 
2015. The aims of the study were 1) to analyse the genetic relatedness between temporally and 98 
geographically matched VREfm and VSEfm and to detect the spread of the vanA plasmid between 99 
different clones, 2) to identify VREfm transmission events between hospitals and 3) to characterize the 100 
pan-genome and plasmids within the largest clonal group accounting for 40% of the VREfm isolates.  101 
 102 
Methods 103 
Setting and bacterial isolates 104 
  
 
 
 
The study was conducted in the Capital Region of Denmark (1.7 million inhabitants) from January 2012 105 
to December 2015. The healthcare system is served by 11 hospitals (one tertiary hospital, four large acute 106 
care secondary hospitals and six minor secondary hospitals). VREfm isolates from all Departments of 107 
Clinical Microbiology (n=3) were submitted consecutively for WGS from 2012-March 2014 (n=338) 108 
whereas only isolates from the Southern part of the region were submitted from April 2014-2015 (n=554). 109 
VREfm screening isolates were identified using selective chromogenic medium and MALDI-TOF. 110 
VREfm in clinical samples were identified using MALDI-TOF and vancomycin disc diffusion according 111 
to EUCAST.13 Only vanA VREfm were included as the vast majority of the isolates contained that 112 
genotype (five isolates contained vanB). One isolate per patient was included. 113 
VSEfm blood isolates from 2013-2014 (n=113) and VSEfm non-blood isolates from 2013-114 
2015 (n=53) were included in the study. Ampicillin resistance was determined using disc diffusion 115 
according to EUCAST.13 116 
Date of sampling, submitting hospital, hospital ward, sample site and sample type (clinical 117 
or screening sample) were collected for all isolates from the laboratory information systems.  118 
VREfm identified from 2012-2014 were sequenced in a previous study.10 All VREfm from 119 
2015 (n=399) and VSEfm (n=166) were sequenced for this study. 120 
 121 
Whole genome short read sequencing and comparative analysis    122 
BDNA extraction and sequencing using Illumina technology were conducted as previously described.7, 10 123 
Sequence reads were mapped to the V24 reference genome (see below) and to individual plasmids using 124 
SMALT.14 Reads at indel sites were realigned using the GATK toolbox.15 SNPs were called using 125 
samtools.16 The variant call file (VCF) was filtered for variants supported by a minimum read depth of 4 126 
(minimum 2 per strand), >30 map quality, >50 average base quality, no significant strand bias and >75% 127 
of reads supporting the variant. Indels were additionally confirmed using pindel.17 Repeat regions of 128 
>50bp and any regions <100 bp between two repeat regions, which are notoriously problematic for short 129 
read mapping, were identified using nucmer and removed from the VCF resulting in consensus 130 
sequences.18 131 
A phylogenetic tree (neighbour-joining tree) including all VREfm and VSEfm isolates was 132 
constructed using RapidNJ and tree visualization was done using FigTree.19, 20 In addition, a subtree of 133 
isolates belonging to the largest clonal group was constructed using RAxML using the general time 134 
reversible model and gamma model of rate heterogeneity. Recombination regions were identified and 135 
removed using ClonalFrameML with a kappa setting of 4, and priors of R/theta = 0.462, 1/delta = 0.004, 136 
nu = 0.042, allowing the rate of recombination to vary per branch.21, 22  137 
 MLST was determined in silico using pubMLST. 138 
 139 
  
 
 
 
Generating a complete genome sequence for a vanA E. faecium isolate using hybrid sequencing 140 
A screening isolate, V24, which was an early representative of the largest VREfm clonal group, was 141 
identified as a reference strain. DNA extraction, Illumina sequencing and PacBio sequencing of V24 were 142 
performed as described previously.7, 10 We achieved a total of 241,971 PacBio reads with a mean length 143 
of 5.8 kb.  144 
V24 was assembled using a hybrid assembly methodology using both short, low error rate 145 
Illumina reads and PacBio long-reads. Reads were assembled by SPAdes v3.6.2 using the --careful, --146 
pacbio, and a manual range of k-mer sizes of 21, 33, 55, 67, 77, 87, 97, 107, 117 and 127.23 Contigs were 147 
scaffolded using SSPACE-longRead,24 and gap filling was performed using PBJelly.25 A single 148 
chromosome and ten non-chromosomal contigs/scaffolds >600 bp were assembled. The chromosome was 149 
found to be largely contiguous with previously published reference genomes after alignment using 150 
MAUVE.26-28 The ten non-chromosomal contig/scaffold sequences were searched against the NCBI nr/nt 151 
database using default megablast settings. Contigs and scaffolds were circularized using an in-house 152 
script as described previously.10 All but one contig were circularisable using this methodology. PCRs 153 
were performed to circularize the last contig, but despite repeated attempts, this did not succeed. 154 
 155 
Characterization of the complete genome V24 156 
 The chromosome and all plasmids were annotated using RAST.29 Resistance genes, 157 
virulence genes, prophages and plasmid replicons were identified via Antibiotic Resistance Gene-158 
ANNOTation, virulenceFinder, Phast and PlasmidFinder online tools, respectively.30-32 Plasmids were 159 
searched for Toxin-antitoxin systems (axe-txe and --) via BLAST according to Rosvoll et al.33 160 
Finally, copy number of plasmids was determined as the mean depth coverage (excluding repeat regions) 161 
of the plasmid divided by the mean depth coverage of the chromosome. 162 
 163 
Presence of ten plasmids in VREfm and VSEfm isolates  164 
Illumina reads from all VREfm and VSEfm isolates were mapped to the ten plasmid sequences generated 165 
from the reference isolate, V24. The depth of coverage, breadth of coverage and the total number of SNPs 166 
(excluding repeat regions) was determined. A plasmid was characterized as present in a sample when at 167 
least 85% of the reference sequence was covered by sufficient reads to call a reference or variant base and 168 
the number of SNPs was ≤5 SNPs per 1000 bp (~99.5% similarity). A reduced breadth of coverage of 169 
≥80% was accepted for plasmid pV24-2 due to large amounts of repeat regions which led to lower 170 
breadth of read coverage (86%) even when mapping the short reads used to create the reference genome, 171 
V24, against itself.  172 
  173 
Pan-genome analysis  174 
  
 
 
 
Reads were assembled de novo using Velvet v1.0.11 and contigs were annotated by Prokka v1.11. The 175 
pan-genome of the largest clonal group was identified by Roary using default settings.34, 35 Core genes 176 
were defined as those present in 99% of the isolates with a minimum percentage amino-acid identity of 177 
95%. We excluded 27 out of 361 isolates (7.5%) from the pan-genome analysis due to poor assemblies 178 
(assemblies of ≥800 contigs). 179 
 180 
Ethics 181 
The project has been approved by the Danish Data Protection Agency (2012-58-0004/AHH-2015-047) 182 
and the Danish Health and Medicines Authority (3-3013-1118/1). 183 
 184 
Results 185 
Descriptive data 186 
In total, 1,058 E. faecium isolates (892 vanA VREfm and 166 ampicillin resistant VSEfm) were included 187 
in the study. A third (n=292, 33%) of the VREfm isolates were from clinical samples and of these isolates 188 
12% (n=35) were from blood cultures. The vast majority of the VREfm isolates (n=832, 93%) were 189 
identified in the five largest hospitals in the region and most VSEfm isolates (n=156, 94%) were 190 
identified in the same five hospitals. More epidemiological data are presented in Table S1. 191 
 192 
Population structure of VREfm 193 
SNP-based phylogeny revealed high diversity between hospital-associated VREfm isolates (Figure 1A). 194 
The isolates were separated into 16 main groups of ≥3 isolates, 10 minor groups of 2 isolates and 25 195 
singletons. The majority, n=728 (81%) of the isolates belong to five groups consisting of 47-361 VREfm 196 
isolates. Clonal group 2_ST80 was the dominant clone from 2012-2015 (Figure 1B). Excluding group 197 
2_ST80, the dominant clonal groups were 1_ST117 and 3_ST192 in 2012-2013 until they were replaced 198 
by clonal groups 8_ST203 and 13_ST80 in 2014-2015. 199 
 200 
Comparative analysis of temporally and geographically matched VREfm and VSEfm  201 
The phylogeny showed that vancomycin-resistant and -susceptible isolates co-occurred within many of 202 
the clonal groups (Figure 1A). In total, n=146 (88%) VSEfm clustered together with VREfm. However, 203 
the largest VREfm group (2_ST80, n=361), responsible for the first local outbreak of VREfm, contained 204 
no VSEfm. Also, clonal groups 8_ST203 and 13_ST80, which were prevalent from 2015, only contained 205 
1 and 0 VSEfm, respectively.  206 
 207 
Epidemiology and spread of clonal group 2_ST80 208 
  
 
 
 
The largest clonal group, 2_ST80, was analysed further in order to understand the rapid dissemination 209 
throughout the region. A maximum likelihood phylogenetic tree, generated for group 2_ST80, was 210 
annotated with hospital location and sampling date (Figure 2A). Further details are presented interactively 211 
using Microreact (https://microreact.org/project/BkNqA1EDX, use Google Chrome as browser).36 Only 212 
samples from 2012 until March 2014 were included (n=142) because sampling coverage was uniform 213 
across the whole region for that time period. Very few SNP differences (mean pairwise SNPs = 8) were 214 
observed between the isolates. The epidemic curve shows that 90% (n=9) of the isolates in 2012 were 215 
sampled from Hospital 1, suggesting that Hospital 1 was the site into which group 2_ST80 was 216 
introduced (Figure 2B). Subsequently, the clone spread to five more hospitals within six months showing 217 
that clonal group 2_ST80 became widespread in the region within less than a year. The phylogenetic tree 218 
branches out in four subgroups. One branch is almost unique to Hospital 2 and the three other branches 219 
contain isolates from four or five hospitals. Assuming that each branch corresponds to a new introduction, 220 
this suggests that clonal group 2_ST80 has been transmitted several times between hospitals in the region 221 
(frequent cross-hospital transmission).  222 
 223 
Genome summary of V24 224 
A representative isolate, V24, of clonal group 2_ST80, was selected for PacBio sequencing to investigate 225 
this successful group further. The genome of V24 included a single circular chromosome (2.7 Mb and 226 
2,625 coding sequences (CDS)), nine circular plasmids with sizes ranging from 4,304 bp to 172,811 bp 227 
(4-178 CDS) and one partial or linear plasmid of 103,806 bp (133 CDS) (Table 1). In total, the genome 228 
contained 3,139 CDS and approximately 14% of the genome was located on plasmids. The best hit in a 229 
blast search against the NCBI nr/nt database for each plasmid were previously published E. faecium 230 
plasmids with query coverages of >60% and similarity of >90%. The exception was the linear/partial 231 
plasmid, pV24-2, that was novel, with query coverage of 15% for the best hit.  232 
The vanA plasmid, pV24-5, was closed in a previous study.10 Re-analyses of PacBio and 233 
Illumina data in this study have extended the plasmid with 4,016 bp (Figure S1). This extension was 234 
confirmed by PCR. The added sequence contained four hypothetic proteins and a replication protein. The 235 
plasmid contained several resistance genes and a BLAST search revealed that the plasmid was similarly 236 
to the non-conjugative plasmid pS177 (Table 1).37 Compared to the Tn1546 prototype characterized by 237 
Arthur et al,38 the vanA transposon was truncated with a deletion of the transposase and 156 bp of the 238 
resolvase. An insertion element (IS1251) was inserted in the vanSH intergenic region. The loss of the 239 
transposase suggests that the element is no longer mobile and genes involved in the mobilization of the 240 
plasmid could not be identified.  241 
  
 
 
 
Genes responsible for conjugation and horizontal transfer (traG) were identified in two 242 
other plasmids, pV24-1 and pV24-3 (Table 1),39 and a BLAST search revealed that pV24-3 was similar to 243 
a highly conjugative plasmid pZB18.40    244 
A search for prophages identified both intact and incomplete prophage regions in the 245 
chromosome and four plasmids. Importantly, the linear/partial plasmid, pV24-2, had three incomplete 246 
prophage regions of which many coding sequences corresponded to sequences in a linear bacteriophage 247 
recently described in a closed E. faecalis genome.41 This may explain why pV24-2 was not circularisable. 248 
Distribution of V24 plasmids among the E. faecium population 249 
V24 plasmids (pV24-1- pV24-10) were much more frequent in VREfm than in VSEfm 250 
isolates (Table 2). Within group 2_ST80 to which V24 belongs, the prevalence of V24 plasmids was 251 
highly variable. Two plasmids were present in <10% of the isolates and four plasmids were present in 252 
>90% of the isolates. This pattern shows that isolates belonging to the same clonal group contain different 253 
large accessory elements. The conjugative plasmid, pV24-3, was only present in group 2_ST80 isolates 254 
identified from 2012-13. After 2013, the plasmid disappeared.  255 
The vanA plasmid (pV24-5) was frequent, n=727 (81%) and spread across all but one 256 
VREfm clonal group (Group 8_ST203). The remaining V24 plasmids were also rare in group 8_ST203 257 
indicating that there has been no exchange of plasmids between the two largest VREfm clonal groups.  258 
 259 
Pan-genome analysis  260 
The pan-genome of group 2_ST80 was identified to assess the distribution between core 261 
genes and accessory genes within a clonal group of highly similar isolates determined by SNP analysis 262 
(mean pairwise SNPs = 8). The pan-genome contained 5,905 genes of which 1,684 were core genes, 263 
2,223 were soft core genes (present in ≥95%) and 2960 were cloud genes (present in <15%) (Figure 3). 264 
We know that the V24 isolate, belonging to group 2_ST80, contained 3,139 CDS. A calculation shows 265 
that approx. 71% (2,223 soft core genes/3,139 CDS) of the V24 genome consisted of conserved and 266 
essential soft core genes and the remaining 29% of the genome consisted of non-essential accessory 267 
genes. 268 
 269 
Discussion 270 
This study provides insights into a polyclonal VREfm outbreak which arose in the Capital Region of 271 
Denmark in 2012. The largest clonal group (2_ST80) accounting for 40% of the isolates was responsible 272 
for the first local VREfm hospital outbreak. This was followed by a rapid clonal expansion and 273 
transmission into multiple hospitals in the region. No VSEfm isolates clustered in this group despite the 274 
large number of isolates sampled, so it can be assumed that clonal group 2_ST80 was imported to the 275 
region as a vancomycin-resistant clone in 2012. A vanA plasmid, pV24-5, initially identified in a group 276 
  
 
 
 
2_ST80 isolate (V24) was observed in 81% of all VREfm isolates (Table 2). We also observed that 277 
VSEfm and VREfm co-occurred in many clonal groups which supports the hypothesis that concurrently 278 
with clonal expansion, group 2_ST80 successfully disseminated pV24-5 via HGT to pre-existing 279 
hospital-adapted VSEfm and new VREfm clones were generated.   280 
Group 2_ST80 spread rapidly (within 6-9 months) to multiple hospitals within the Capital 281 
Region after its introduction to hospital 1 (Figure 2). This remarkable fast transmission is likely a product 282 
of the highly interlinked healthcare network within the region, with medical specializations consolidated 283 
into only a few Hospitals, which results in frequent transfer of patients between hospitals (approximately 284 
1,500 patients per month between hospitals, data from Department of Financial Affairs, the Capital 285 
Region of Denmark). VREfm colonized patients are asymptomatic carriers, and transfer of those patients 286 
represents a great risk of starting a new VREfm outbreak. In previous studies, clonally related VREfm 287 
isolates were identified in hospitals that rarely share patients and a community reservoir was suggested.27, 288 
28, 42-46 In contrast, our genomic analyses and epidemiological data support a hospital reservoir for the 289 
dominant clonal group (2_ST80). 290 
From the beginning of the VREfm outbreak, barrier precautions, extra cleaning, 291 
disinfection with chlorine and VREfm screening of contact patients were initiated. Active surveillance 292 
screening programmes were not systematically introduced at the same time in all hospitals in the region 293 
which may explain continued expansion of VREfm.  294 
The increase of VREfm and results from the present study prompted several measures to 295 
control VREfm: 1) Switch from a culture based methods to vanA/vanB PCR to achieve faster results (<24 296 
hours) and higher sensitivity, 2) Active surveillance screenings of wards with ≥2 VREfm patients, 3) 297 
VREfm screening of patients transferred from another hospital to high risk departments, 4) Screening and 298 
isolation of VREfm patients readmitted within six months and 5) real-time sequencing of VREfm isolates 299 
(results within 1-2 weeks) to include/exclude patients from outbreaks and to better understand 300 
transmission routes. 301 
In 2015, clonal group 8_ST203 emerged (Figure 1). This group did not contain the 302 
successful vanA plasmid, pV24-5, and only one VSEfm clustered in the group suggesting import and 303 
spread of yet another successful VREfm clonal group. Recently, the Danish Reference Laboratory at 304 
Statens Serum Institut closed a genome of an early (October 2014) group 8_ST203 isolate.42, 47 A vanA 305 
plasmid, pVRE1589 (CP020486), different from pV24-5 (Figure S1), was identified. Ninety-seven 306 
percent of the isolates in clonal group 8_ST203 contained pVRE1589 (Henrik Hasman, Department of 307 
Bacteria, Parasites and Fungi, Statens Serum Institut, personal communication). Introduction of a clonal 308 
group containing a new vanA plasmid indicates that the hospital environment in the Capital Region has 309 
become favorable for VREfm within the last five years, as the prevalence of VREfm was less than 20 310 
isolates per year before 2012.8, 9 Important factors to drive the current emergence of VREfm could be 311 
  
 
 
 
increasing use of vancomycin and metronidazole due to a large Clostridium difficile outbreak, shift of 312 
empirical therapy from cefuroxime to piperacillin-tazobactam and increasing tolerance for disinfectants 313 
among E. faecium isolates.48-52 314 
WGS-based typing is an important tool for infection control to define nosocomial 315 
outbreaks, include/exclude patients from an outbreak and to identify transmission events. In this work we 316 
identified widespread dissemination of a vanA-containing plasmid. Short read sequencing allowed for 317 
cost-effective epidemiological analysis and isolate screening on a large scale. Long-read sequencing 318 
allowed us to resolve problematic regions of the genome, such as plasmids, which were relevant to the 319 
current work. Based on this study we recommend using a combination of long-read and short-read 320 
sequencing for bacteria with highly variable accessory genome content to interpret outbreaks correct. 321 
The present study identified a large number of MGEs in VREfm with 14% of the coding 322 
capacity located on plasmids in V24. This was in line with the pan-genome analysis of group 2_ST80 323 
which identified acquisition of a highly heterogeneous accessory genome (Figure 3) suggesting frequent 324 
flux of MGEs. This flexible and mobile genome may contribute to the success of the clone by providing it 325 
with ready access to genes which enable it to adapt to new environmental changes. Lack of the CRISPR-326 
Cas system, which provides bacteria with sequence-specific, acquired defense against plasmids and 327 
phage, was suggested as an explanation for the high number of MGEs in enterococci.53 Previous studies 328 
have reported up to six plasmids per E. faecium genome with 9-10% of the genome located on 329 
plasmids.27, 28, 42-44 Potential donors to the heterogeneous accessory genome could be other intestinal 330 
bacteria as E. faecium is part of a complex community in the GI-tract. However, previous studies showed 331 
that sequence importation in relation to recombination was mainly from other E. faecium populations.54, 55 332 
The vanA plasmid, pV24-5, was highly similar to plasmid pS177, which was identified in a 333 
VREfm isolate from USA more than ten years ago and recently a pS177-like plasmid was reported in 334 
Australia, suggesting that the plasmid is globally spread.37, 44 The plasmid, pS177, is a non-conjugative 335 
plasmid lacking the transposase in Tn1546 which indicates that the element is not mobile.37 Presumably, 336 
the vanA plasmid, pV24-5, used the conjugation machinery from another conjugative plasmid to 337 
disseminate via HGT. Adding PacBio sequencing to close the genome of V24 revealed a conjugative 338 
plasmid, pV24-3, which was present in all group 2_ST80 isolates identified from 2012 until September 339 
2013 (Table 2). This suggests that pV24-3 may have played an important role in the horizontal transfer of 340 
the vanA plasmid. From 2014, pV24-3 disappeared from the clone and was either replaced by another 341 
conjugative plasmid or the ability to disseminate the vanA plasmid was lost. This may explain why clonal 342 
groups 1_ST117 and 3_ST192 almost disappeared in 2015 (Figure 1). However, the vanA plasmid, pV24-343 
5 was also present in clonal group 13_ST80 which became quiet dominant in 2015. Our knowledge of 344 
conjugative transfer systems and plasmid interactions is sparse and hopefully, long-read sequencing will 345 
  
 
 
 
improve our understanding of this. Also, experimental characterization of the required attributes for 346 
mobility and other accessory genetic elements contributing to this would be valuable. 347 
The strength of this study is the large number of contemporary VREfm and VSEfm 348 
isolates that are included. Inclusion of VSEfm data, which is new compared to our previous study on 349 
VREfm has provided valuable information on the close relationship between VREfm and VSEfm.10 350 
Completion of a vanA genome enabled us to assess the plasmid content and provided us with a reference 351 
genome closely related to the outbreak we are investigating. However, this study has limitations. We 352 
expect that the plasmid population is much larger than investigated in this study. In addition, mixed 353 
infections may have been overlooked due to the sampling methodology of selecting only one colony for 354 
sequencing from each patient. 355 
In conclusion, we have shown that a successful VREfm clone was imported to a VREfm 356 
low prevalence region in Denmark in 2012. Both clonal expansion and generation of new VREfm clonal 357 
groups via horizontal transfer of a vanA plasmid to pre-existing VSEfm contributed to the sudden increase 358 
and persistence of VREfm. This combination of clonal spread and plasmid spread must be recognized to 359 
interpret VREfm hospital outbreaks correctly and highlights the added value of long-read sequencing in 360 
WGS. 361 
The acquisition of a highly heterogeneous accessory genome and the high number of 362 
plasmids within group 2_ST80 showed that there is no single successful combination of accessory genes, 363 
suggesting that VREfm isolates belonging to this clone can rapidly acquire genes to optimize survival in 364 
the harsh hospital environment between transmissions. 365 
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A 563 
B  564 
 565 
Figure 1: A. SNP-based phylogeny of 892 vanA E. faecium (VREfm) and 166 vancomycin-susceptible E. 566 
faecium (VSEfm) identified in the Capital Region of Denmark from 2012-2015. Eight outliers have been 567 
removed from the phylogenetic tree. Each circle represents a main group and was scaled in relation to the 568 
number of isolates in the group. The pie charts show the proportion of VREfm (grey) and VSEfm (white) 569 
isolates within each main group. Circles are located near the centre of the group on the phylogenetic tree. 570 
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The group numbers are assigned according to when the group was first identified and according to ST. 571 
Group identification number, number of isolates, percentage of VSEfm isolates in each main group and 572 
percentage of clinical VREfm out of all VREfm are given in the table. B. The number of VREfm 573 
belonging to the five largest clonal groups divided by calendar years. 574 
 575 
 576 
 577 
 578 
Figure 2: A. Phylogenetic tree of clonal group 2_ST80, 2012- March 2014 with masking of 579 
recombination. Coloured circles represent the hospital origin of each of the isolates. The nested circular 580 
shapes represent the approx. sampling times with inner circle contains isolates sampled until December 581 
2012 and the outer circle contains isolates sampled until June 2013. Isolates outside the circles are 582 
sampled from July 2013 to March 2014. Data are presented interactively at 583 
https://microreact.org/project/BkNqA1EDX (use Google Chrome as browser).36 B. Epidemic curve of 584 
clonal group 2_ST80, 2012- March 2014. This figure appears in colour in the online version of JAC and 585 
in black and white in the printed version of JAC. 586 
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 593 
Figure 3: Visualization of the pan-genome of group 2_ST80 (n=334 isolates). Each line represents an 594 
isolate. Presence of a gene is indicated in black and absence of a gene in white. Core genes (present in 595 
≥99% of the isolates), soft core genes (present in ≥95% of the isolates), accessory genes (present in <95% 596 
of the isolates), shell genes (present in <95% and ≥15% of the isolates) and cloud genes (present in <15% 597 
of the isolates) are indicated. The isolates are vertically ordered based on similarity in a NJ-tree. 598 
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Genome Size (bp) 
GC con-
tent (%) 
CDS 
Circula
-risable 
Copy 
number 
Virulence 
genes 
Resistance 
Genes 
rep 
types 
 Prophage regions 
Other 
features 
Blast search in 
NCBI 
Chromo-
some 
2,720,495 38.2 2.625 Yes 1 Acm 
msrC, dfrG, 
tetM 
 
2 intact (28.7 kb, 35.9 
kb), 1 questionable 
(14.8 kb) and 1 
incomplete (18 kb) 
  
pV24-1 172,811 35.3 178 Yes 1 HylEfm Aac6_Aph2 15 1 intact (24.8 kb) traG 
Ef AUS00233, coverage 
73%, 99% identical 
pV24-2 103,806 33.4 133 No 3    
3 incomplete (7.9 kb, 
10.8 kb, 11.6 kb) 
 Ef 6E6 p1, coverage 
15%, 99% identical 
pV24-3 61,681 33.0 70 Yes 2     traG 
Ef pZB18 DNA, cove-
rage 90%, 99% identical 
pV24-4 41,792 35.4 47 Yes 3  
aph(3')-III, 
ant(6)-Ia, sat4A, 
tetS 
2 1 intact (24.5 kb)  
Ef p5753cB, partial 
sequence, coverage 
67%, 99% identical 
pV24-5 41,388 35.4 51 Yes 3  
aph(3')-III, 
ant(6)-Ia, sat4A, 
ermB, vanA 
17 
1 incomplete (24.5 
kb) 
Txe-axe 
Ef  pS177, coverage 
88%, 99% identical 
pV24-6 9,317 30.8 12 Yes 3     
Bacte-
riocin 
Ef AUS0085 p4, 
coverage 100%, 100% 
identical 
pV24-7 6,173 35.5 8 Yes 6   11  
Bacte-
riocin 
Ef pB82,coverage 
100%, 100% identical 
pV24-8 5,954 33.3 6 Yes 7   18   
Ef pVEF4,coverage 
61%, 91% identical 
pV24-9 4,465 32.1 4 Yes 5      
Ef pHY DNA, coverage 
61%, 99% identical 
pV24-10 4,304 37.1 5 Yes 10      
Ef AUS0004 p2, cove-
rage 82%, 97% identical 
Table 1: Summary of the vanA E. faecium genome of V24. 623 
CDS: coding sequences, Acm: collagen adhesion gene, HylEfm: Hyaluronidase gene, Aac6_Aph2, 624 
aph(3')-III, ant(6)-Ia and sat4A: resistance genes of aminoglycosides, vanA: resistance genotype of 625 
vancomycin, msrC and ermB: resistance genes of lincosamides, dfrG: resistance gene of trimethoprim, 626 
tetS and tetM: resistance genes of tetracyclin, traG: transfer gene, Txe-axe: Toxin-antitoxin system, Ef: E. 627 
faecium. 628 
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 637 
 638 
 639 
 640 
 641 
 642 
 643 
  
 
 
 
   Group n pV24-1 pV24-2 pV24-3 pV24-4 pV24-5 pV24-6 pV24-7 pV24-8 pV24-9 pV24-10 
  ------------------------------------------------------------------- n (%) --------------------------------------------------------------------- 
   1_ST117 111 4 (4) 98 (88) 0 (0) 1 (1) 99 (89) 5 (5) 108 (97) 107 (96) 29 (26) 21 (19) 
   2_ST80 361 15 (4) 227 (63) 103 (29) 167 (46) 357 (99) 29 (8) 359 (99) 350 (97) 340 (94) 257 (71) 
   3_ST192 47 43 (91) 12 (26) 0 (0) 0 (0) 44 (94) 1 (2) 42 (89) 42 (89) 45 (96) 42 (89) 
   4_ST80 24 2 (8) 12 (50) 0 (0) 1 (4) 19 (79) 0 (0) 15 (63) 17 (71) 19 (79) 15 (63) 
   5_ST80 15 0 (0) 13 (87) 0 (0) 0 (0) 15 (100) 0 (0) 14 (93) 4 (27) 2 (13) 3 (20) 
   7_ST117 16 0 (0) 1 (6) 0 (0) 1 (6) 15 (94) 0 (0) 16 (100) 16 (100) 2 (13) 2 (13) 
   8_ST203 119 1 (1) 37 (31) 0 (0) 1 (1) 1 (1) 0 (0) 118 (99) 1 (1) 8 (7) 4 (3) 
   9_ST117 10 10 (100) 9 (90) 0 (0) 0 (0) 7 (70) 0 (0) 10 (100) 10 (100) 3 (30) 3 (30) 
  10_ST80 26 0 (0) 11 (42) 0 (0) 0 (0) 20 (77) 0 (0) 26 (100) 13 (50) 26 (100) 13 (50) 
  11_ST80 8 0 (0) 8 (100) 0 (0) 0 (0) 8 (100) 0 (0) 8 (100) 8 (100) 0 (0) 0 (0) 
  12_ST18 9 2 (22) 5 (56) 0 (0) 0 (0) 4 (44) 0 (0) 3 (33) 3 (33) 2 (22) 1 (11) 
  13_ST80 90 84 (93) 46 (51) 0 (0) 1 (1) 89 (99) 0 (0) 90 (100) 89 (99) 90 (100) 61 (68) 
  Others 56 20 (36) 33 (59) 2 (4) 3 (5) 45 (80) 8 (14) 46 (82) 44 (79) 34 (61) 23 (41) 
  Total    
  VREfm 
892 181 (20) 512 (57) 105 (12) 175 (20) 723 (81) 43 (5) 854 (96) 704 (79) 600 (67) 444 (50) 
            
  Total  
  VSEfm 
166 16 (10) 33 (20) 0 (0) 0 (0) 0 (0) 12 (7) 123 (74) 116 (70) 31 (19) 14 (8) 
Table 2: Plasmid distribution (pV24-1 to pV24-10) among vancomycin-resistant E. faecium (VREfm), 644 
vancomycin-susceptible E. faecium (VSEfm) and the 12 largest VREfm clonal groups. 645 
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